Pharmadeel : Healthcare Company in UAE | Medical Services & Patient Care Solution | Since 2020

Sucrosomial® Iron Technology: A Breakthrough in Iron Supplementation

Since 2003, PharmaNutra has specialized in developing innovative solutions for iron supplementation. Our scientific research focuses on creating safer, more effective methods for addressing iron deficiency across various medical fields.

Through collaborations with leading Italian universities and international research foundations, we've developed Sucrosomial® Iron - a superior alternative to conventional iron supplements. Key benefits include:

• Reduced gastrointestinal side effects
• Improved patient compliance
• Decreased need for intravenous iron
• Lower healthcare costs
• Enhanced absorption technology

Recent Scientific Studies on Sucrosomial® Iron:

• Karavidas An et al. Oral Sucrosomial iron improves exercise capacity and quality of life in heart failure with reduced ejection fraction and iron deficiency: A nonrandomized, open-label, proof-of-concept study. Eur J Heart Fail 2021 Jan 9.
• Bertani L et al. Oral Sucrosomial Iron is as effective as intravenous Ferric Carboxy-Maltose in treating anemia in patients with Ulcerative Colitis. Supplements 2021, 13, 608.
• Bastida G et al. Sucrosomial Iron supplementation for the treatment of iron deficiency anemia in Inflammatory Bowel Disease patients refractory to oral iron treatment. Supplements 2021, 13, 1770.
• Asperti M et al. Iron distribution in various tissues of homozygous Mask (msk/msk) mice and the effects of oral iron treatments. Am J Hematol. 2021;1–11.
• Reggiani F et al. Initial experience on the use of sucrosomial iron in hemodialysis: Focus on safety, hemoglobin maintenance, and oxidative stress. Int Urol Nephrol. 2021 Sep 12.
• Mazgaj R et al. Comparative evaluation of Sucrosomial Iron and iron oxide nanoparticles as oral supplements in iron deficiency anemia in piglets. Int J Mol Sci. 2021 Sep 14;22(18):9930.
• Zakrzewski M et al. Supplementation with Sucrosomial iron induces positive changes in the gut microbiome compared to ferrous sulfate in mice.

Source: PharmaNutra S.P.A